Subsequent cellular experiments confirmed that METTL3 plays a significant role in COPD pathogenesis by modulating the NF‐kB‐MPO pathway, leading to reduced HDAC2 expression. The gene discussed is HDAC2; the disease is chronic obstructive pulmonary disease.